Genetic Engineering News and Research

RSS

Researchers highlight when antireflux surgery is needed to treat GERD after endoscopy

Researchers report a growing awareness of gastroesophageal reflux problems among patients who undergo endoscopic, nonsurgical treatment for esophageal achalasia, frequently requiring future surgical intervention.

8 Apr 2020

Understanding early visual processing steps could have implications for schizophrenia, ADHD

Researchers at the National Eye Institute (NEI) have defined a crucial window of time that mice need to key in on visual events.

8 Apr 2020

Personalized biohybrid microswimmers for therapeutic cargo delivery

Tiny biohybrid robots on the micrometer scale can swim through the body and deliver drugs to tumors or provide other cargo-carrying functions. The natural environmental sensing tendencies of bacteria mean they can navigate toward certain chemicals or be remotely controlled using magnetic or sound signals.

7 Apr 2020

Australian plant that produces antibodies may help in coronavirus vaccine production

As the world reels from the rising number of cases of COVID-19 disease caused by SARS-CoV-2, an Australian scientist, Prof. Peter Waterhouse from Laboratory of Molecular Genetics (LMG) at Queensland University of Technology (QUT), is working with a native plant from Australia that shows potential in the fight against SARS-CoV-2.

7 Apr 2020

Study reveals how serotonin balances communication within the brain

Our brain is steadily engaged in soliloquies. These internal communications are usually also bombarded with external sensory events.

7 Apr 2020

Researchers identify new biomarker to track the development of NAFLD

Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide.

7 Apr 2020

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

OXGENE™ and The Native Antigen Company today announced a collaboration to scale up production of SARS-CoV-2 (COVID-19) reagents.

2 Apr 2020

Information overload on COVID-19 leads people to pick out bizarre, unhelpful choices

That the COVID-19 situation has been accompanied by a relentless flood of information is evident from a quick examination of newspaper front pages, top stories on any news channel, or trending topics on Twitter.

1 Apr 2020

Stellenbosch University and AzarGen Biotechnologies join forces to tackle COVID-19

Stellenbosch University in South Africa and AzarGen Biotechnologies (Pty) Ltd, a South African biotechnology company focused on developing human therapeutic proteins using advanced genetic engineering and synthetic biology techniques in plants, have joined forces in the global fight against the coronavirus.

31 Mar 2020

'Living drug factories' could be used to achieve long-term treatment of chronic diseases

One promising way to treat diabetes is with transplanted islet cells that produce insulin when blood sugar levels get too low.

30 Mar 2020

Study quantifies economic burden of CVD in women with a history of preterm delivery

A new study quantifies the future economic burden of cardiovascular disease (CVD) in women with a history of preterm delivery.

30 Mar 2020

Researchers develop a 'cardiac patch with bioink' to repair the heart

The heart is the driving force of circulating blood in the body and pumps blood to the entire body by repeating contraction and relaxation of the heart muscles continuously.

30 Mar 2020

Gene that could affect the progress of ALS discovered

Researchers from the Zuckerman Institute at Columbia University have successfully found a gene that could work towards accelerating the progression of ALS or amyotrophic lateral sclerosis. The study titled, "The loss of TBK1 kinase activity in motor neurons or in all cell types differentially impacts ALS disease progression in SOD1 mice," was published in the latest issue of the journal Neuron.

29 Mar 2020

New in vivo priming strategy can be an effective means to enhance cardiac repair

Human stem cells have been regarded as one of the promising cell sources for cardiac regeneration therapy.

27 Mar 2020

Accurate and informative labeling of CBD products is a critical public health issue

The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue.

25 Mar 2020

Advancing CAR T-cell therapy for treatment of solid tumors

The full title of the research is "The study of the mechanisms of effectiveness of T-cells CAR-T towards solid tumors"; it was supported by nonprofit RakFond (Cancer Fund) and CyStoreLab (a resident of Skolkovo).

25 Mar 2020

A genetic toolkit to produce multifunctional magnetic nanoparticles

Magnetic bacteria might soon be used for the production of novel biomaterials. A team of microbiologists at the University of Bayreuth led by Prof. Dr. Dirk Schüler developed a modular system for the genetic reprogramming of bacteria, thereby turning the organisms into cell factories for multifunctional magnetic nanoparticles that combine various useful functions and properties.

25 Mar 2020

Combination produces more proliferative, enduring central memory T cells for cellular therapy

Treating T cells harvested from a patient with a combination of an epigenetic drug and a cytokine while expanding the cells in the lab re-programs them into a stronger T cell type that persists longer than its comrades, researchers at The University of Texas MD Anderson Cancer Center report in Cancer Immunology Research, a journal of the American Association for Cancer Research.

25 Mar 2020

CELLINK starts reselling a real-time qPCR instrument

CELLINK has started reselling a qPCR instrument. The instrument uses a laboratory technique of molecular biology based on the polymerase chain reaction.

From CELLINK 25 Mar 2020

German scientists test TB vaccine against coronavirus

The coronavirus disease (COVID-19) had taken a toll on the world, affecting 168 countries and more than 417,000 people. So far, more than 18,600 people have died due to complications of the disease. Scientists across the globe race to develop the first vaccine against the novel coronavirus.

24 Mar 2020

Genetic Engineering News and Research

Researchers highlight when antireflux surgery is needed to treat GERD after endoscopy

Understanding early visual processing steps could have implications for schizophrenia, ADHD

Personalized biohybrid microswimmers for therapeutic cargo delivery

Australian plant that produces antibodies may help in coronavirus vaccine production

Study reveals how serotonin balances communication within the brain

Researchers identify new biomarker to track the development of NAFLD

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

Information overload on COVID-19 leads people to pick out bizarre, unhelpful choices

Stellenbosch University and AzarGen Biotechnologies join forces to tackle COVID-19

'Living drug factories' could be used to achieve long-term treatment of chronic diseases

Study quantifies economic burden of CVD in women with a history of preterm delivery

Researchers develop a 'cardiac patch with bioink' to repair the heart

Gene that could affect the progress of ALS discovered

New in vivo priming strategy can be an effective means to enhance cardiac repair

Accurate and informative labeling of CBD products is a critical public health issue

Advancing CAR T-cell therapy for treatment of solid tumors

A genetic toolkit to produce multifunctional magnetic nanoparticles

Combination produces more proliferative, enduring central memory T cells for cellular therapy

CELLINK starts reselling a real-time qPCR instrument

German scientists test TB vaccine against coronavirus

Genetics & Genomics - Second Edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo